Prevent Quality Failures Before They Happen
Quality Intelligence That Predicts Risk Before It Strikes
Transform regulatory data, quality signals, and operational evidence into actionable risk insight. Predict, prioritize, and prevent quality risk before it escalates.
The Challenge
Quality risk is no longer driven by isolated deviations or individual audit findings. Regulators increasingly evaluate organizations based on patterns: repeat issues, weak controls, inconsistent execution, and lack of management oversight. Yet most companies still manage quality risk reactively.
- Quality data scattered across audits, deviations, CAPA, validation, and documents
- No consistent baseline to measure compliance or maturity
- Overreliance on periodic audits and subjective judgment
- Limited ability to identify systemic or repeat issues
- Inability to anticipate inspection outcomes
Built on Regulatory Truth, Not Guesswork
Regller Quality Intelligence is grounded in regulatory source data, not generic risk models. From these sources, Regller has built thousands of structured, traceable assessment questions, controls, and evidence expectations that define what “good” looks like from a regulatory perspective.
FDA Title 21 CFR
Decoded and structured regulatory requirements forming the baseline for quality assessment and compliance verification.
FDA QMM Framework
Quality Management Maturity practice areas and assessment criteria aligned with FDA expectations.
Global Standards
ICH guidelines (Q8-Q12), GAMP 5, CSA principles, and global GMP and inspection practices integrated into the platform.
Learning from FDA Inspections
Regller maps internal quality data to external regulatory signals to help organizations understand where regulators are likely to focus, which gaps are most likely to escalate, and how internal quality signals translate into regulatory risk.
- FDA inspection trends mapped to your quality posture
- Publicly available FDA 483s and warning letter themes analyzed
- Repeat and systemic issue patterns identified
- Industry-wide enforcement focus areas tracked
- Internal weaknesses correlated with known inspection outcomes
Turning Quality Data Into Actionable Intelligence
From raw quality signals to predictive risk insight in four steps.
01. Signal Collection
Aggregate quality signals from deviations, CAPAs, audit findings, complaint trends, batch records, supplier data, and environmental monitoring.
02. Pattern Recognition
AI algorithms analyze historical and real-time quality data to identify patterns invisible to manual review. Correlations across seemingly unrelated events reveal systemic risks.
03. Risk Prediction
Predictive models score and rank emerging risks by likelihood and impact. See which areas of the business are trending toward failure before a deviation occurs.
04. Early Warning
Real-time dashboards surface the most critical quality signals. Configurable alerts notify the right people when risk indicators exceed thresholds.
Quality Intelligence in Action
Deviation Trend Prediction
Identify manufacturing processes trending toward out-of-specification results before a batch fails. Early intervention saves product, time, and regulatory exposure.
Supplier Risk Monitoring
Continuously monitor supplier quality signals to predict which suppliers are most likely to deliver non-conforming materials. Take preventive action before supply chain disruptions occur.
Inspection Readiness
Analyze your quality metrics against FDA inspection focus areas. Identify and remediate gaps before the inspector arrives.
Predict Quality Risk Before It Escalates
Move from reactive quality management to proactive risk prevention.
Ready to Get Started?
Connect with our team to learn how Regller can transform your quality management.